Carla Cox, PhD, registered dietician and certified diabetes educator, discusses key information about COVID-19 that individuals with diabetes should know.
Apotex Corp is voluntarily recalling all lots of metformin hydrochloride extended-release tablets, USP 500 mg, within expiry to retail level.
CMS is reducing insulin copays for seniors who are eligible for Medicare via an executive order from President Donald Trump.
Months after FDA said it was investigating the carcinogenic ingredient NDMA in metformin products, the agency’s testing has found elevated levels of NDMA in extended release metformin, but not in the immediate release formulation.
A new study suggests that well-controlled blood sugar may reduce mortality for patients with diabetes and COVID-19.
A new study evaluated methods of improving heart function in individuals with type 2 diabetes.
Insulin manufacturers are expanding insulin affordability options for patients with diabetes during the coronavirus pandemic.
The American Heart Association’s scientific statement outlines medications, procedures, and lifestyle change recommendations for individuals with both type2 diabetes and coronary artery disease.
V-Go® may provide a more affordable option for insulin therapy.
Pharmacists can play an integral role in managing patients with diabetes.